Clinical Trial Update: Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating multiple-dose safety, tolerability, pharmacokinetics, and midazolam interaction in healthy overweight and obese adults, with type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Midazolam (Midazolam)

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED